{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:03:03Z","timestamp":1788822183777,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00858-2","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:03:08Z","timestamp":1709546588000},"page":"397-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case of Duchenne muscular dystrophy recovered from prolonged ischemic kidney injury which emerged with a normal creatinine level"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9578-3824","authenticated-orcid":false,"given":"Kensuke","family":"Daikoku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"858_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifir\u00f2 G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15:141.","journal-title":"Orphanet J Rare Dis"},{"key":"858_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","volume":"21","author":"Y Ishikawa","year":"2011","unstructured":"Ishikawa Y, Miura T, Aoyagi T, Ogata H, Hamada S, Minami R. Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord. 2011;21:47\u201351.","journal-title":"Neuromuscul Disord"},{"key":"858_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.5692\/clinicalneurol.51.743","volume":"51","author":"T Matsumura","year":"2011","unstructured":"Matsumura T, Saito T, Fujimura H, Shinno S, Sakoda S. A longitudinal cause-of-death analysis of patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku. 2011;51:743\u201350.","journal-title":"Rinsho Shinkeigaku"},{"key":"858_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","volume":"61","author":"M Horio","year":"2013","unstructured":"Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S, GFR CDtJEfE. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197\u2013203.","journal-title":"Am J Kidney Dis"},{"key":"858_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mus.21420","volume":"40","author":"L Viollet","year":"2009","unstructured":"Viollet L, Gailey S, Thornton DJ, Friedman NR, Flanigan KM, Mahan JD, et al. Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve. 2009;40:438\u201342.","journal-title":"Muscle Nerve"},{"key":"858_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1536\/ihj.15-461","volume":"57","author":"K Kimura","year":"2016","unstructured":"Kimura K, Morita H, Daimon M, Horio M, Kawata T, Nakao T, et al. Utility of cystatin C for estimating glomerular fltration rate in patients with muscular dystrophy. Int Heart J. 2016;57:386\u20138.","journal-title":"Int Heart J"},{"key":"858_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nmd.2015.01.005","volume":"25","author":"E Braat","year":"2015","unstructured":"Braat E, Hoste L, De Waele L, Gheysens O, Vermeersch P, Goffin K, et al. Renal function in children and adolescents with Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25:381\u20137.","journal-title":"Neuromuscul Disord"},{"key":"858_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ki.1985.205","volume":"28","author":"O Shemesh","year":"1985","unstructured":"Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830\u20138.","journal-title":"Kidney Int"},{"key":"858_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0009-8981(00)00298-9","volume":"300","author":"N Cimerman","year":"2000","unstructured":"Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000;300:83\u201395.","journal-title":"Clin Chim Acta"},{"key":"858_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5692\/clinicalneurol.52.211","volume":"52","author":"T Matsumura","year":"2012","unstructured":"Matsumura T, Saito T, Fujimura H, Sakoda S. Renal dysfunction is a frequent complication in patients with advanced stage of Duchenne muscular dystrophy. Rinsho Shinkeigaku. 2012;52:211\u20137.","journal-title":"Rinsho Shinkeigaku"},{"key":"858_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.nmd.2015.07.006","volume":"25","author":"T Motoki","year":"2015","unstructured":"Motoki T, Shimizu-Motohashi Y, Komaki H, Mori-Yoshimura M, Oya Y, Takeshita E, et al. Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients. Neuromuscul Disord. 2015;25:754\u20137.","journal-title":"Neuromuscul Disord"},{"key":"858_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nmd.2016.07.010","volume":"26","author":"CR Villa","year":"2016","unstructured":"Villa CR, Kaddourah A, Mathew J, Ryan TD, Wong BL, Goldstein SL, et al. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C. Neuromuscul Disord. 2016;26:637\u201342.","journal-title":"Neuromuscul Disord"},{"key":"858_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/mus.26757","volume":"61","author":"T Motoki","year":"2020","unstructured":"Motoki T, Shimizu-Motohashi Y, Saito I, Komaki H, Ishiyama A, Aibara K, et al. Renal dysfunction can occur in advanced-stage Duchenne muscular dystrophy. Muscle Nerve. 2020;61:192\u20137.","journal-title":"Muscle Nerve"},{"key":"858_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mus.880030306","volume":"3","author":"LJ Kagen","year":"1980","unstructured":"Kagen LJ, Moussavi S, Miller SL, Tsairis P. Serum myoglobin in muscular dystrophy. Muscle Nerve. 1980;3:221\u20136.","journal-title":"Muscle Nerve"},{"key":"858_CR15","first-page":"831","volume":"63","author":"Y Adachi","year":"2021","unstructured":"Adachi Y, Tamura R, Shindo T, Sasaki K, Masaki T, Nozu K, et al. A case of hereditary FSGS with Duchenne muscular dystrophy diagnosed in childhood. Jpn J Nephrol. 2021;63:831 (In Japanese).","journal-title":"Jpn J Nephrol"},{"key":"858_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17:347\u201361.","journal-title":"Lancet Neurol"},{"key":"858_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JND-200609","volume":"8","author":"R Quinlivan","year":"2021","unstructured":"Quinlivan R, Messer B, Murphy P, Astin R, Mukherjee R, Khan J, et al. Adult North Star Network (ANSN): consensus guideline for the standard of care of adults with Duchenne muscular dystrophy. J Neuromuscul Dis. 2021;8:899\u2013926.","journal-title":"J Neuromuscul Dis"},{"key":"858_CR18","unstructured":"Suehara M, Nagata A, Saito M, Kanzato N. 2cases of trying positive treatment to further complication after appearance of cardiopulmonary function failure In: Ministry of health and welfare editor. Reports of the clinical research team for the genetic counselling and the clinical research of the pathophysiology and treatment in muscular dystrophy patients. Kodaira: National Center of Neurology and Psychiatry; 1999. p. 430 (In Japanese)"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00858-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T15:13:33Z","timestamp":1727795613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00858-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00858-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}